Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

recombinant FVIIa × Classical hematology × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Interventions

Cyclophosphamide 86 fludarabine phosphate 77 Busulfan 55 Cyclosporine 52 Epoetin Alfa 51 Whole-Body Irradiation 49 Mycophenolic Acid 48 Peripheral Blood Stem Cell Transplantation 44 fludarabine 41 Melphalan 37 Cytarabine 37 Darbepoetin alfa 35 Antilymphocyte Serum 35 Filgrastim 34 Tacrolimus 33 Methotrexate 29 Radiotherapy 28 Cord Blood Stem Cell Transplantation 26 Rivaroxaban 20 Granulocyte Colony-Stimulating Factor 20 Etoposide 20 Methylprednisolone 19 apixaban 18 Dalteparin 16 eltrombopag 15 ferric carboxymaltose 14 epoetin beta 14 Thiotepa 14 Azacitidine 14 Alemtuzumab 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02622321 2021-06-24

HAVEN 1

Hoffmann-La Roche

Phase 3 Completed

113 enrolled 45 charts 1 FDA

Classical hematology

Hemophilia A

Data powered by HemOnc (CC BY 4.0) Colophon ⚡